TSH-secreting pituitary adenoma treated conservatively with cabergoline for more than 10 years

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.

Preoperative control of hyperthyroidism in patients with TSH-secreting pituitary adenomas (TSHoma) may avoid perioperative thyroid storm. Perioperative administration of octreotide may control hyperthyroidism, as well as shrink tumor size. The effects of preoperative octreotide treatment were assessed in a large number of patients with TSHomas. Of 81 patients who underwent surgery for TSHoma at...

متن کامل

TSH-Secreting Pituitary Adenoma: Current Management and Review.

The neurosurgical literature contains little information about the current management of patients with thyroid-stimulating hormone (TSH)-secreting pituitary adenomas or about the usefulness of the somatostatin analogue octreotide in such cases. While TSH-secreting pituitary adenomas are rare, our review and illustrative case demonstrate the effectiveness of pretreating patients with octreotide ...

متن کامل

A Case of Thyrotropin-Secreting Pituitary Adenoma (TSH-oma)

Thyrotropin-secreting pituitary adenomas (TSHomas) are rare tumors and represent about 1-2% of all pituitary adenomas (prevalence is about one case per million) and cause secondary or central hyperthyroidism. The number of reported cases of TSH-omas tripled in the last decade. The increased number of reported cases resulted principally from the introduction of ultrasensitive immunometric assay ...

متن کامل

TSH-secreting pituitary adenoma: benefits of pre-operative octreotide

UNLABELLED TSH-secreting pituitary adenomas are rare and the optimal investigation and management is uncertain. We describe a case of a 43 year-old woman with a TSH-secreting pituitary adenoma, highlighting diagnostic testing and our use, pre-operatively of somatostatin analogue therapy, which induced biochemical euthyroidism and a reduction in tumour size. LEARNING POINTS The differential di...

متن کامل

Shrinkage of thyrotrophin secreting pituitary adenoma treated with octreotide.

Thyrotrophin secreting pituitary adenomas are a rare cause of recurrent thyrotoxicosis. We report on a 47 year old woman with an 8-year history of this condition. In this case the somatostatin analogue, octreotide, normalized thyroid hormone levels. It was associated with marked tumour shrinkage, with striking reduction of the suprasellar extension and improved appearances in the region of the ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Endocrine Abstracts

سال: 2014

ISSN: 1479-6848

DOI: 10.1530/endoabs.35.p847